Cogen Immune Medicines
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Cogen Immune Medicines
Private Company Edition: VC mega-rounds boosted the Q1 2021 total. Also, new funds from Versant, The Column Group and Rapha Capital keep cash flowing into biopharma; up to $525m is invested in Exscientia; and Arch Oncology and Boundless Bio raised $105m each, while Forge brought in $120m.
- Gene Therapy, Cell Therapy
- Other Names / Subsidiaries
- Cogen Immune Medicines
- Repertoire Immune Medicines
- Torque Therapeutics, Inc.